Vitasang Corporation is a US life sciences company focused on blood banking and transfusion innovation, founded by Hanuman Medical, inventor of the Tuned Density Float office-based platelet rich plasma separation technology (US7992725B2).
Vitasang specializes in Extracorporeal Blood Washing and has acquired Rejuvesol™, a product designed to rejuvenate cells, particularly erythrocytes (red blood cells). Rejuvesol™ is FDA-approved for the extracorporeal rejuvenation of blood to treat anemia. By rejuvenating transfused red blood cells, Rejuvesol™ enhances oxygen delivery. The process of restoring stored blood cells is known as blood rejuvenation.
Vitasang is working with experts in the scientific community on future developments for Rejuvesol including exploration of the potential to treat hypoxia and improve oncology outcomes in hypoxic tumours.
Meet our team
Our team spans all aspects of pharmaceutical development and commercialisation backed up by a high calibre board and advisory panel.
Scott King
Founder
Paul Steckler
CEO
Rick Storrs
CSO
Mike Leach
COO
Scott King – Founder and President of Hanuman Medical, creating and patenting new medical technologies. In addition to founding and managing Islet SheetMedical and PlasmaSeal, Scott was Wall Street’s first biotechnology industry analyst. Scott was educatedat the University of Chicago (B.S.) and HarvardUniversity (M.A.).
Paul Steckler – C-Suite executive and board member with a distinguished careerspanning over 25 years. As the Chief Commercial Officer at ShieldTherapeutics, he successfully raised £75 million during thecompany’s IPO. Paul led the turnaround of the International business whilst at Canopy Growth, achieving profitability with revenues close to $100 million while overseeing a workforce of over 500 employees and orchestrating successful M&A activities resulting in three successful exits. Paul gained extensive experience across more than 15 therapy areas whilst commercial director at Pfizer. Dedicated to philanthropic causes, he serves as a trustee for BRACE, a charity focused on dementia research. Paul holds a BSc(Hons) in Microbiology & Virology from the University of Warwick.
Rick Storrs – Rick has over 20 years of experience in cell biology, design,and engineering across industry and academia. Prior roles include VP R&D at Hanuman Medical, and as COO at Cerco Medical, Sr. Scientist at Plasmaseal, and Lead Scientist at Depo Tech. Rick is a co-inventor of more than a dozen patented technologies and author of numerous peer-reviewed papers. Rick was trained as a protein chemist atUniversity of California, Berkeley (PhD) and drug delivery scientist (NIH Postdoctoral Fellow, Stanford).
Mike Leach – Mike has over 20 years of experience in design, development, and operations within the medical device industry with Zimmer Biomet. Mike began hiscareer in the aerospace industry. Mike is a co-inventor on more than 40 patents and 60+ patentapplications. Mike has a B.S. degree from GraceCollege.
Prof Matt Kaeberlein
Non Exec Director
Prof James White
Advisor
Prof Gurpreet Baht
Advisor
Antony Sommerfield
Non Exec Director
Prof Matt Kaeberlein – He is the founding director of the Healthy Aging and Longevity Research Institute at the University of Washington and has authored more than 200 scientific papers exploring the intricate processes of aging. Matt is a leading figure in the study of age-related biology, with expertise extending across various aspects of aging, including the identification of genetic and environmental factors that influence lifespan and healthspan. He has received numerous prestigiousawards in recognition of his contributions to aging research,including the Breakthroughs in Gerontology (BIG) Award andthe Vincent Cristofalo Rising Star in Aging Research Award.
Prof James White – A stalwart at Duke University, holding esteemed positions as an Assistant Professor in Medicine and Assistant Research Professor in Cell Biology. He is also an active member of the Duke Molecular Physiology Institute. His affiliation extends to the Duke Cancer Institute, the Duke Regeneration Center, and as a Senior Fellow in the Center for the Study of Aging. James’ academic journey began with an M.S. from Florida State University, leading to a Ph.D. from the University of South Carolina,Columbia, and culminating as a Postdoctoral Fellow at Harvard Medical School.
Prof Gurpreet Baht – is a distinguished Assistant Professor in Orthopaedic Surgery and Pathology at Duke University. He actively contributes to the Duke Molecular Physiology Institute and is an affiliate of the Duke Regeneration Center. Gurpreet’s academic foundation was laid at the University of Western Ontario, Canada, where he earned his Ph.D. in 2009.
Antony Sommerfield – Managing Director at AIP, a capital introduction, advisory, and services firm to the Lifesciences, Commodities, and Technology sectors. He is regularly involved in multi-million dollar capital raising and M&A deals. Antony is the Chairman of the Sustainability AI firm GeonatIQ and the founder of the Carbon Storage platform CSP. Previously, he was afounding partner at Adamant Ventures, an investment fund, and co-founder of DRS, an international search firm. Antony is a graduate of Imperial College London and UCL, with advanced AI training from MIT and Oxford University
Prof Matt Kaeberlein
Non Exec Director
Prof James White
Advisor
Alan Gray – Experienced in Drug and Device Product Development, Quality(QA/QC), Regulatory Affairs, and as a Research Scientist with 40+years in the Pharmaceutical and Medical Device industries and in Academic Clinical/Biotechnology Research. Highly experienced in RBC testing/evaluation of Rejuvesol Red Blood Cell Processing Solution treated RBCs and manufacturing Rejuvesol treated RBC for clinical evaluation prior to commercialisation. Named inventor on 9 Patents.Technical writing including authorship/co-authorship on 33 peer-reviewed scientific publications. Currently the Development Associate Director at Zimmer Biomet. Formerly VP Technology and VP QualityControl at Citra Labs. Alan holds a Master of Science Degree from University of Massachusetts, Lowell, in Biological Sciences(experimental haematology) and a Bachelor of Science Degree fromUniversity of Massachusetts, Lowell in Biological Sciences.
Matt Landrigan – Biotech and Medical Device R&D projects. 9 years of medical device development, 3 years of late stage drug development and 3 years of clinical strategy and execution. Licensed Patent Agent with 9 issued patents as a named inventor. Skilled in multi-million dollar Biotech Research and Medical Devices programs, Clinical Research, Patent Law, and Medical Device Manufacturing. Program management experience includes leading complex global multi-disciplinary internal and externally facing teams. Technical writing includes 8 Manuscripts and more than 25 conference abstracts. PhD in Biomechanical Engineering and Masters Degree in Mechanical Engineering from Notre Dame, Bachelor of Science Degree from Purdue University Fort Wayne in Mechanical Engineering.
FAQs
What is your vision for the future?
Vitasang believes that recent clinical developments has accelerated the need for blood rejuvenation. This is coupled with an ongoing blood shortage. Vitasang will improve healthspan through blood management.
Who is behind Vitasang?
Vitasang was founded by Hanuman Medical. Hanuman have a history of over 30 years working on development of med tech solutions. Moreover Hanuman have significant experience in blood management and adjacent development.
I am interested in investing, how do I get more information?
In the first instance feel free to get in touch via our contact page. We would love to discuss our business plans.
Can I apply to be a part of the team?
Vitasang is not currently recruiting but as the business develops and grows we will post new roles on this site. Alternatively you can follow our LinkedIn page where will share any active roles.